India and New Zealand have signed a new free trade agreement offering zero-duty access for Indian goods. This pact aims to boost exports in sectors like pharmaceuticals, machinery, and agriculture by removing tariffs. Indian businesses now gain a competitive edge in a high-income market that previously relied on other global suppliers.
India and New Zealand have officially entered into a new Free Trade Agreement (FTA) designed to lower trade barriers and increase bilateral commerce. Under the terms of this deal, Indian goods will gain unconditional, zero-duty access to New Zealand. In exchange, India has agreed to phase out import duties on approximately 95% of products originating from New Zealand over a set period. This move is significant for Indian exporters who are looking to diversify their presence in high-income economies.
Targeting New Export Segments
The agreement is particularly important for sectors where Indian presence in New Zealand has historically been low, despite the country's high import demand. For instance, New Zealand imports nearly $140 million worth of immunological products, such as insulin injections and blood-typing reagents, yet Indian participation in this segment has been minimal. Similarly, the market for forklifts sees New Zealand importing roughly $60 million annually, while Indian manufacturers, despite having a strong global export footprint, have had negligible sales there. The tariff removal provides a crucial price advantage that could help Indian firms compete against existing suppliers.
Strengthening Established Export Hubs
Beyond opening new doors, the FTA is expected to reinforce India’s leadership in sectors where it already enjoys a significant market share. Indian exporters currently hold between 70% and 95% of New Zealand's total imports in categories such as spices, rice, jewelry, and carpets. By eliminating duties, the pact lowers the cost for New Zealand buyers, which could lead to increased order volumes for Indian producers in these traditional areas.
Pharmaceutical and Engineering Growth Potential
The pharmaceutical sector presents one of the most substantial opportunities for growth. While India’s global pharmaceutical exports are valued at nearly $20 billion, its shipments to New Zealand account for only $69 million out of a total import market of $763 million. Similarly, in the jewelry market, Indian products currently capture less than 25% of New Zealand's $108 million demand. Other sectors such as engineering goods, chemicals, automobiles, and electronics are also expected to benefit from this easier access.
However, the ultimate impact on company revenues will depend on more than just the removal of tariffs. Success will be determined by the ability of Indian companies to manage logistics effectively, maintain competitive pricing, and meet the specific regulatory requirements of the New Zealand market. Investors should monitor how export companies adapt their supply chains to leverage these new opportunities, as well as the pace at which New Zealand’s import demand for these specific categories grows in the coming quarters.